Carolina Liquid Chemistries

Name

Carolina Liquid Chemistries

Legal name

Carolina Liquid Chemistries Corp.

Website

https://carolinachemistries.com

Company type

Private

Founded year

1994

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Clinical Laboratory Instruments

NAICS

Analytical Laboratory Instrument Manufacturing (334516), In-Vitro Diagnostic Substance Manufacturing (325413), Medical Equipment and Supplies Manufacturing (3391)

SIC

Laboratory Analytical Instruments (3826), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Clinical Chemistry & Hematology Diagnostics (automated analyzers, blood testing) (HLAAALAH)

akta.pro secondary industries

Analytical Instruments & Chromatography Systems (HLAGAIAA), Laboratory Consumables & Plasticware (Tips, Tubes, Plates, Filters) (HLAGAIAH)

Keywords

• Clinical chemistry analyzers
• Chemistry reagents
• Veterinary chemistry analyzers
• Immunoassay analyzers
• Laboratory instruments

Headquarters

HQ city

Greensboro

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Chemistry Analyzers and Instruments (Hardware): Sale of branded and distributed chemistry analyzers ranging from benchtop models (DZ-Lite c270, EasyRA) to floor models (CLC800, CLC1600, CLC6410), as well as refurbished Olympus AU series and BioLIS 24i/CLC480 analyzers. Hardware sales are one-time purchases with accompanying service contracts.
2. Reagents and Consumables: Recurring revenue from sale of chemistry reagents for clinical analyzers, including general chemistries (40+ assays), toxicology/urine drug screens (27+ assays), special chemistries (24+ including Lp-PLA2, Vitamin D, Procalcitonin, Cystatin C, Free Light Chains), and CLIA-moderate-complexity categorized assays. Reagents are sold as barcoded, liquid, ready-to-use cartridges and consumables with recurring purchase cycles.
3. Service Contracts and Support: Aftermarket service contracts covering instrument repair, preventative maintenance, hotline support, remote diagnostics, installation, and validation assistance for analyzers. Contracts are available for all CLC analyzer models, Olympus AU systems, Beckman Synchron, and BioLIS systems. On-site service response within 24 hours and phone response within 15 minutes.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels7 records

Core offering

Carolina Liquid Chemistries designs, manufactures, and distributes clinical chemistry analyzers (including the branded CLC family and resold benchtop/floor-model systems) along with a broad menu of clinical chemistry reagents, immunoassay and hematology analyzers, veterinary analyzers, and supporting service contracts. The company serves clinical laboratories of all sizes — from small physician office labs to large reference and hospital labs — with ISO 13485-certified, FDA-registered US-based manufacturing and reagent production.

Product overview

Carolina Liquid Chemistries is a provider of clinical chemistry analyzers, reagents, and laboratory services for clinical laboratories of all sizes. The company offers its own branded CLC Family of clinical chemistry analyzers (CLC6410, CLC1600, CLC800, CLC480/BiOLiS 24i) ranging from benchtop to high-volume floor models, alongside resold products from partners including Medica (EasyRA), Diazyme (DZ-Lite c270), Tosoh (AIA immunoassay analyzers and G8 HPLC), Mindray (hematology analyzers), and Seamaty (veterinary analyzers). The product portfolio includes a comprehensive reagent menu of over 100 general chemistry and toxicology reagents, special chemistry assays (Vitamin D, Lp-PLA2, Procalcitonin, etc.), and refurbished equipment options. The company provides complete lab solutions combining chemistry, immunoassay, and hematology analyzers with associated reagents and services including installation, training, validation assistance, and service contracts.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• Over 95% customer satisfaction rate year-over-year
• +3 more outcomes

Named customers6 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Six partnerships are on record, tiered minor and core.

• Kamiya Biomedical CompanyminorStrategic or Co-development Partner · 30 November 2023CLC partnered with Kamiya Biomedical Company to obtain CLIA moderate complexity categorization for K-ASSAY® Microalbumin reagent for use on the Medica EasyRA® benchtop clinical chemistry analyzer. The reagent is intended for the quantitative determination of human albumin in urine by immunoturbidimetric assay, aiding in kidney dysfunction diagnosis.
• Diazyme Laboratories, Inc.coreStrategic or Co-development Partner · 20 January 2023CLC and Diazyme announced a partnership to expand the test menu on the Diazyme DZ-Lite c270 benchtop clinical chemistry analyzer. The partnership added 25 new assays (including Lp-PLA2, APO A1, APO B, Homocysteine, Vitamin D, and other esoteric tests) to the DZ-Lite c270, enabling it to run both special chemistries and routine chemistries. Diazyme is a Life Science Affiliate of General Atomics, cGMP and ISO 13485 certified.
• SeamatycoreChannel Partner/ Reseller/ Distributor · 1 March 2021Carolina Liquid Chemistries signed a semi-exclusive agreement to distribute Seamaty's SMT-120VP and SMT-120V Veterinary Automated Chemistry Analyzers in the USA. The partnership expanded CLC's offerings into the veterinary market, providing portable, cost-effective biochemistry, electrolyte, immunoassay, and coagulation testing for veterinary practices and mobile labs.
• TosohcoreChannel Partner/ Reseller/ DistributorCLC partnered with Tosoh to supply immunoassay analyzers (AIA-360, AIA-900, AIA-2000) and the G8 HPLC HbA1c analyzer. Tosoh analyzers are distributed by CLC in the USA and are selected for their exceptionally high quality yet economical product offerings, providing a complete immunoassay solution as part of CLC's complete lab offerings.
• MindraycoreChannel Partner/ Reseller/ DistributorCLC partnered with Mindray to supply hematology analyzers (BC-3600, BC-5390) as part of its complete laboratory solution offering. Mindray analyzers were selected for their high quality yet economical pricing, completing CLC's full-suite laboratory product line (chemistry, immunoassay, and hematology).
• Spectrum Chemical Mfg. Corp.minorOthersSpectrum Chemical Mfg. Corp. is a leading global provider of fine chemicals, lab equipment, and supplies serving more than 120 industries. Since 2003, CLC and GenChem (medical device companies owned by Philip and Patricia Shugart) have sourced fine chemicals from Spectrum for use in producing high-quality, cost-effective reagents. In celebration of Spectrum's 50th anniversary, CLC's Brea, CA production facility was honored as one of a select group of customers recognized for their partnership.

Scale indicators4 records

Recent moves9 records

Expansion highlights6 records

Direct peers

• Bio-Rad Laboratories: Bio-Rad manufactures and sells clinical chemistry, immunology, and life science research instruments and reagents, including a long-standing clinical diagnostics business built on a similar specialty/reagent model as CLC. Both companies serve mid-sized and reference clinical labs with proprietary assays and OEM instruments.
• ELITech Group: ELITech is a specialty clinical chemistry and immunoassay manufacturer with a comparable size, channel mix, and reagent-centric business model. Its U.S. distribution footprint and focus on small/mid-sized labs make it a close analog to CLC's positioning.
• Randox Laboratories: Randox manufactures clinical chemistry analyzers and a broad, proprietary reagent menu (including toxicology and specialty assays), and competes head-to-head in the open-system, mid-throughput segment where CLC's CLC/EasyRA/DZ-Lite products sit. Its reagent and analyzer model mirrors CLC's razor/blade economics.
• Erba Mannheim: Erba Mannheim is a global clinical chemistry and hematology manufacturer with a similar open-system, mid-throughput, cost-disruptive positioning. It serves small and mid-sized labs worldwide with analyzers and reagents in the same price/performance tier as CLC's benchtop and floor-model lines.
• HORIBA Medical: HORIBA Medical manufactures clinical chemistry and hematology analyzers with a focus on small-to-mid-volume labs, and is a direct competitor in the benchtop and floor-model chemistry analyzer segment where CLC's EasyRA, DZ-Lite, and CLC family compete. Both companies emphasize compact footprint and open reagent systems.
• Mindray: Mindray is both a CLC distribution partner (BC-3600, BC-5390 hematology) and a broader peer in clinical chemistry and hematology analyzers. Mindray's U.S. clinical lab footprint and economical open-system positioning make it a directly comparable manufacturer/distributor in adjacent product lines CLC sells.

Broad incumbents

• QuidelOrtho: QuidelOrtho is a large clinical diagnostics incumbent spanning immunoassay, clinical chemistry, and molecular diagnostics. While broader and more diversified than CLC, it competes in many of the same clinical lab segments and represents the type of scaled competitor CLC must differentiate against with its open-system, cost-focused approach.
• Siemens Healthineers: Siemens Healthineers operates a large clinical chemistry and immunoassay portfolio (Atellica, ADVIA Centaur) aimed at hospital and reference labs. It is a broad incumbent whose scale and closed-system reagent economics create the price umbrella CLC's open-system, lower-cost reagents and analyzers target.
• Roche Diagnostics: Roche Diagnostics (cobas) is a global clinical chemistry and immunoassay leader with the dominant share of large hospital and reference lab placements. CLC explicitly positions against the high cost of Roche and other OEM reagents, making Roche the strategic reference point for CLC's value proposition.
• Abbott Diagnostics: Abbott Diagnostics (Alinity ci, Architect) is a global clinical chemistry, immunoassay, and point-of-care incumbent. The August 2025 CLC alcohol assay CLIA categorization on the Abbott ImmTox 270 illustrates the dual relationship: Abbott is both a competitor and an instrument platform on which CLC's reagents are validated.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/CarolinaLiquidChemistries
• LinkedInlinkedin.com/company/carolina-liquid-chemistries-corp-
• Xx.com/carolinachem

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Carolina Liquid Chemistries